Developing diagnostic and
prognostic tools for patients with IgA nephropathy.
The GalD Assay: An Independent Predictor of Kidney Outcomes in IgA Nephropathy
The GalD Assay: An Independent Predictor of Kidney Outcomes in IgA Nephropathy
Research Use Only
IgA nephropathy (IgAN, also called Berger’s disease) is a glomerular kidney disease in which an antibody, IgA, accumulates in the microscopic filters of the kidneys. This buildup causes irritation and damage over
time, reducing the capacity of, the kidneys to clean the blood.
Some people may not notice symptoms at first, but the most common signs are:
IgAN leads to serious kidney problems in most patients. Doctors diagnose IgAN with a kidney biopsy. While there isn’t a cure yet, doctors can use medicines and healthy-lifestyle changes to slow the decline in kidney function.
We’re happy to hear from you. Contact us today to learn more about our expertise, assay kits, and how you can benefit from working with us.
For general inquiries, email info@reliantglycosciences.com. For questions in regards to placing an order or purchase history, email purchasing@reliantglycosciences.com.